Sofie grabs $5M Series A for PET imaging development; Grove Instruments' glucometer attracts $3.3M;

@FierceMedDev: Natera expands prenatal test amid global push. ICYMI yesterday | Follow @FierceMedDev

@MarkHFierce: Who are this year's FMD Fierce 15 winners? Find out here | Follow @MarkHFierce

@MichaelGFierce: Critical Diagnostics launches point-of-care cardiac disease test. Item | Follow @MichaelGFierce

> Sofie Biosciences raised a new $5 million Series A funding round toward development of new PET imaging probes and new imaging systems to help researchers trying to uncover the biology of disease. Item

> NeuroMetrix ($NURO) has inked a deal with a major clinic owner to start carrying the company's Sensus non-invasive nerve stimulation device to treat pain. Item

> Brookhaven Medical, an Atlanta-based maker of dialysis and wound care devices, snatched up Wound Management Technologies in Fort Worth, TX. Item

> Grove Instruments in Worcester, MA, raised a $3.3M Series B-2 financing to fuel further development of its noninvasive glucometer. Item

> Toumaz has signed a deal to propel distribution of its low-power system designed for wireless monitoring of patient vital signs. Story

> Guided Therapeutics signed distribution deals to expand access to its advanced cervical scanning system in markets in France, Qatar, Malaysia, Indonesia and Bangladesh. Story

Biotech News

@FierceBiotech: Analysts offer giddy forecasts for booming cancer immunotherapy pipeline. More | Follow @FierceBiotech

@JohnCFierce: PhIII blunders that have helped define companies, for better or worse. The top Phase III R&D setbacks of 2013 | Follow @JohnCFierce

@DamianFierce: If Myriad was a big dog in a small park in its fight with Ambry and Gene by Gene, Quest is a dog colossus. | Follow @DamianFierce

> AstraZeneca buys Spirogen in $440M deal, inks pact in armed antibody double-play. Story

> Aerie Pharma craves $84.5M in amped-up offering as IPOs pour in. More

> Sanofi plots more cuts at slow-footed French R&D shop. Article

Pharma News

@FiercePharma: Biggest new news Monday: Irate Teva reps vow to strike against Israeli job cuts. Story | Follow @FiercePharma

@CarlyHFierce: Sanofi nabs OTC nod for Nasacort amid consumer healthcare push. ICYMI yesterday | Follow @CarlyHFierce

> J&J hikes earnings forecast on pharma's superhero sales flight. More

> Savient gives up the ghost; buyer aims to snap up Krystexxa. Article

Biotech Research News

@EmilyMFierce: Parkinson's may take two forms, one more toxic than the other. More | Follow @EmilyMFierce

> Vegetable-based compound protects against side effects of radiation therapy. Story

> Evotec gets $5.4M from Boehringer Ingelheim in cancer research pact. Report

> Compound halts neurodegeneration in mice. More

> Gene therapy plus stem cells quickens wound healing. Article

> Boston University, MRC Technology developing anti-inflammatory antibody. Item

Pharma Manufacturing News

@EricPFierce: MHRA says it also took action against Wockhardt contractor Nestor in U.K. as part of recent action. Article | Follow @EricPFierce

> U.S. awards special status to fired Novartis workers. Report

> Israeli unions threaten strikes over Teva job cuts. Item

> FDA closes out inspection on Ranbaxy New Jersey plant. More

> SAFC adds biologics capabilities at 2 plants. News

> Roche expanding biologics production in 3 countries. Story

Suggested Articles

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.

Infectious disease blood tester Karius has raised $165 million led by SoftBank’s Vision Fund 2, the Japanese conglomerate’s sequel to its VC megafund.

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.